2.15

2.27% -0.05

Mdxhealth Sa (MDXH)

Overview News Price History Discussions Forecast

Mdxhealth Sa stock is traded at $2.15, with a volume of 78,387. It is down -2.27% in the last 24 hours and down -2.27% over the past month. MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Previous Close:

$2.20

Open:

$2.2

24h Volume:

78,387

Relative Volume:

0.63

Market Cap:

$106.42M

Revenue:

$63.69M

Net Income/Loss:

$-44.82M

P/E Ratio:

-1.075

EPS:

-2

Net Cash Flow:

$-30.56M

1W Performance:

-6.52%

1M Performance:

-2.27%

6M Performance:

-25.35%

1Y Performance:

-52.01%

1-Day Range:

$2.09

$2.23

1-Week Range:

$2.09

$2.41

52-Week Range:

$1.55

$4.50

Mdxhealth Sa Stock (MDXH) Company Profile

Name

Mdxhealth Sa

Sector

Healthcare (1233)

Industry

Diagnostics & Research (57)

Phone

Address

Employee

300

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

MDXH's Discussions on Twitter

Compare MDXH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDXH Mdxhealth Sa	2.15	106.42M	63.69M	-44.82M	-30.56M	-2.00
TMO Thermo Fisher Scientific Inc	544.93	208.44B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	238.09	171.97B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	137.00	39.13B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	204.32	37.08B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	432.36	35.40B	3.84B	866.24M	792.60M	10.37

Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-31-24	Initiated	Lake Street	Buy
May-31-23	Initiated	TD Cowen	Outperform
Jul-18-22	Resumed	Oppenheimer	Outperform

Mdxhealth Sa Stock (MDXH) Latest News

Dec 25, 2024

Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World

Dec 25, 2024

Dec 17, 2024

Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World

Dec 17, 2024

Dec 13, 2024

MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics (NASDAQ:MDXH) - Seeking Alpha

Dec 13, 2024

Dec 08, 2024

MDxHealth (STU:O6C1) Enterprise Value : €88.51 Mil (As of Dec. 08, 2024) - GuruFocus.com

Dec 08, 2024

Dec 01, 2024

MDxHealth (CHIX:MDXHB) Enterprise Value : €102.00 Mil (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 28, 2024

MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN

Nov 28, 2024

Nov 25, 2024

MDxHealth to Participate in Piper Sandler Healthcare Conference - The Manila Times

Nov 25, 2024

MDxHealth CEO to Present at Piper Sandler Healthcare Conference in NYC | MDXH Stock News - StockTitan

Nov 25, 2024

Nov 24, 2024

OneDigital Investment Advisors LLC Increases Stock Position in MDxHealth SA (NASDAQ:MDXH) - Defense World

Nov 24, 2024

Nov 21, 2024

MDxHealth SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024

Nov 19, 2024

MDxHealth stock hits 52-week low at $1.57 amid market challenges By Investing.com - Investing.com South Africa

Nov 19, 2024

MDxHealth stock hits 52-week low at $1.57 amid market challenges - Investing.com

Nov 19, 2024

Nov 18, 2024

OC500 2024: Michael McGarrity - Orange County Business Journal

Nov 18, 2024

Nov 15, 2024

AWM Investment Company's Strategic Acquisition of MDxHealth SA S - GuruFocus.com

Nov 15, 2024

Nov 12, 2024

MDxHealth stock hits 52-week low at $1.93 amid market challenges - Investing.com

Nov 12, 2024

Nov 07, 2024